SEC Form 4 · accession 0001209191-19-005266
Nightstar Therapeutics plc · NITE
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Senthil Vel Sundaram
Officer — Chief Financial Officer
Period of report
Jan 22, 2019
Accepted (ET)
Jan 24, 2019 · 9:05 pm EST
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001711675
Table I — non-derivative securities
No Table I lines on this filing.
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Stock Option (Right to Buy)F1,F2 | $14.74 | Jan 22, 2019 | A | 108,700 | A | — | Jan 21, 2029 | Ordinary Shares | 108,700 | 108,700 | D |
Explanation of responses
- F1This option will vest as to 25% on January 1, 2020. The remainder of the underlying shares will vest in 36 equal monthly installments thereafter.
- F2The ordinary shares, nominal value GBP 0.01 per share, of the Issuer may be represented by American Depositary Shares ("ADSs"). Each ADS represents one ordinary share of the Issuer.